Literature DB >> 18377712

Migration and distribution of bone marrow stromal cells in injured spinal cord with different transplantation techniques.

Li Fan1, Fei DU, Bang-chang Cheng, Hao Peng, Shi-qing Liu.   

Abstract

OBJECTIVE: To study the regularity of migration and distribution of bone marrow stromal cells (BMSCs) in injured spinal cord with intradural space transplantation.
METHODS: Forty Wistar rats were randomly assigned into 4 groups. The spinal cord injury model was prepared according to the modified Allen method. BMSCs were labeled by CM-Dil. And 5.0 multiply 10(6) cells were transplanted by different channels including intraventricular injection (Group A),injured spinal cord intrathecally injection (Group B), remote intrathecally injection at the L(3)-L(4) level (Group C), and intravenous injection (Group D). Spinal cord was dissected at 24 hours, 1, 2, 3 and 4 weeks after transplantation. Sections of 4 micromolar were cut on a cryostat and observed under fluorescence microscopy.
RESULTS: No fluorescence was observed 24 hours after transplantation in spinal cord injury parenchyma except Group B. One week later, BMSCs in Groups A and C began to migrate to the injured parenchyma; 2-4 weeks later, BMSCs penetrated into the injured parenchyma except Group D. The number of BMSCs decreased at 3-4 weeks after transplantation. The number of cells in Group B decreased faster than that of Groups A and C.
CONCLUSIONS: BMSCs transplanted through intraventricular injection, injured spinal cord intrathecally injection and remote intrathecal injection could migrate to the injured parenchyma of spinal cord effectively. The number of BMSCs migrated into injured spinal cord parenchyma is rare by intravenous injection.

Entities:  

Mesh:

Year:  2008        PMID: 18377712     DOI: 10.1016/s1008-1275(08)60020-6

Source DB:  PubMed          Journal:  Chin J Traumatol        ISSN: 1008-1275


  7 in total

Review 1.  A systematic review of cellular transplantation therapies for spinal cord injury.

Authors:  Wolfram Tetzlaff; Elena B Okon; Soheila Karimi-Abdolrezaee; Caitlin E Hill; Joseph S Sparling; Jason R Plemel; Ward T Plunet; Eve C Tsai; Darryl Baptiste; Laura J Smithson; Michael D Kawaja; Michael G Fehlings; Brian K Kwon
Journal:  J Neurotrauma       Date:  2010-04-20       Impact factor: 5.269

2.  Current stem cell treatments for spinal cord injury.

Authors:  R Vawda; J Wilcox; Mg Fehlings
Journal:  Indian J Orthop       Date:  2012-01       Impact factor: 1.251

Review 3.  Cellular treatments for spinal cord injury: the time is right for clinical trials.

Authors:  Michael G Fehlings; Reaz Vawda
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

4.  Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.

Authors:  Areesak Chotivichit; Monchai Ruangchainikom; Pipat Chiewvit; Adisak Wongkajornsilp; Kittipong Sujirattanawimol
Journal:  J Med Case Rep       Date:  2015-04-09

5.  Factors affecting directional migration of bone marrow mesenchymal stem cells to the injured spinal cord.

Authors:  Peng Xia; Su Pan; Jieping Cheng; Maoguang Yang; Zhiping Qi; Tingting Hou; Xiaoyu Yang
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

6.  Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI.

Authors:  Katherine A Ruppert; Karthik S Prabhakara; Naama E Toledano-Furman; Sanjna Udtha; Austin Q Arceneaux; Hyeonggeun Park; An Dao; Charles S Cox; Scott D Olson
Journal:  PLoS One       Date:  2020-05-26       Impact factor: 3.240

7.  Adipose-derived mesenchymal stem cells rescue rat hippocampal cells from aluminum oxide nanoparticle-induced apoptosis via regulation of P53, Aβ, SOX2, OCT4, and CYP2E1.

Authors:  Mona M Atia; Alshaimaa A I Alghriany
Journal:  Toxicol Rep       Date:  2021-06-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.